
Division of Pathology, Department of Molecular Biology, Medical Biochemistry and Pathology

Sponsors
SILVER
At Merck, also known as MSD outside the United States and Canada, we are united in a single purpose: using the power of modern science to save and improve lives around the world. For more than 130 years, we have been bringing hope to humanity through the development of important medicines and vaccines.
A leader in innovation in oncology. Thanks to its ongoing commitment to research and development of cutting-edge treatments for people with cancer, our portfolio includes breakthrough drugs such as: - Tagrisso™ (osimertinib) for lung cancer (EGFR) - Lynparza™ (olaparib) for ovarian, breast, prostate, and pancreatic cancers (BRCA or ATM) - Imfinzi™ (durvalumab) for lung cancer and certain biliary cancers - Enhertu™ (trastuzumab deruxtecan, developed in collaboration with Daiichi Sankyo) for HER2+ breast, gastric, and lung cancer - Truqap (capivesertib) for breast cancer (AKT, PIK3CA, or PTEN) - Calquence (acalabrutinib), a BTK inhibitor for chronic lymphocytic leukemia and small lymphocytic lymphoma We We work closely with clinical institutions and healthcare professionals to promote access to precision medicine in Canada. AstraZeneca is actively involved in training, the development of innovative diagnostic solutions, and clinical research to ensure patients benefit from recent advances in oncology and personalized medicine.
BRONZE
AbbVie's mission is to discover and deliver innovative medicines that address significant health needs today and the medical challenges of tomorrow. It strives to make a remarkable impact on people's lives in key therapeutic areas, including immunology, oncology, neuroscience, eye care, virology, and gastroenterology, as well as in aesthetics through Allergan Aesthetics products and services.
.png)


